A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides

Madeleine Duvic, Matthew L. Sherman, Gary S. Wood, Timothy M. Kuzel, Elise Olsen, Francine Foss, Robert J. Laliberté, John L. Ryan, Kristilyn Zonno, Alain H. Rook

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides'. Together they form a unique fingerprint.

Medicine & Life Sciences